Browse > Article
http://dx.doi.org/10.3340/jkns.2011.50.2.75

Leukoaraiosis on Magnetic Resonance Imaging Is Related to Long-Term Poor Functional Outcome after Thrombolysis in Acute Ischemic Stroke  

Choi, Jae-Hyung (Department of Neurosurgery, Neurology, Medical Science Research Center, College of Medicine, Dong-A University)
Bae, Hyo-Jin (Department of Neurology Busan-Ulsan Regional Cardiocerebrovascular Center, Medical Science Research Center, College of Medicine, Dong-A University)
Cha, Jae-Kwan (Department of Neurology Busan-Ulsan Regional Cardiocerebrovascular Center, Medical Science Research Center, College of Medicine, Dong-A University)
Publication Information
Journal of Korean Neurosurgical Society / v.50, no.2, 2011 , pp. 75-80 More about this Journal
Abstract
Objective : Leukoaraiosis (LA) has been suggested to be related to the poor outcome or the occurrence of symptomatic intracerebral hemorrhage (sICH) after acute ischemic stroke. We retrospectively investigated the influences of LA on long-term outcome and the occurrence of sICH after thrombolysis in acute ischemic stroke (AIS). Methods : In this study, we recruited 164 patients with AIS and magnetic resonance image (MRI)-detected thrombolysis. The presence and extent of LA were assessed using the Fazekas grading system. The National Institutes of Health Stroke Scale score was used to assess the baseline measure of neurologic severity, and the modified Rankin Scale score assessment was used up to 1 year after thrombolysis. Results : Of 164 subjects, 56 (34.2%) showed LA on MRI. Compared to the 108 patients without LA, the patients with LA were of much older age (p<0.01), had a higher prevalence of hypertension (p<0.01), and had a much poorer outcome at 90 days (p=0.05) and 1 yr (p=0.01) after thrombolysis. There were no significant differences in sICH between patients with and without LA on MRI. In univariate analysis for the occurrence of poor outcome at 90 days after thrombolysis, the size of ischemic lesion on diffusion weighted images (DWI), [odds ratio (OR), 1.03; 95% confidence interval (95% CI), 1.01-1.04; p<0.01], recanalization (OR, 0.03; 95% CI, 0.01-0.10; p<0.01), sICH (OR, 12.2; 95% CI, 1.54-95.8), neurologic severity (OR, 1.17; 95% CI, 1.09-1.25; p<0.01), blood glucose level (OR, 1.01; 95% CI, 1.00-1.02; p=0.03), and the presence of LA on MRI (OR, 2.01; 95% CI, 1.04-3.01; p=0.04) were statistically significant. In multivariate analysis, neurologic severity (OR, 1.14; 95% CI, 1.04-1.24; p<0.01), recanalization (OR, 0.03; 95% CI, 0.01-0.11; p<0.01), lesion size on DWI (OR, 1.02; 95% CI, 1.01-1.03; p=0.02), serum glucose level (OR, 1.01; 95% CI; 1.01-1.02; p=0.03), and the presence of LA on MRI (OR, 3.2; 95% CI, 1.22-8.48; p<0.01) showed statistically significant differences. These trends persisted up to 1 yr after thrombolysis. Conclusion : In this study, we demonstrated that the presence of LA on MRI might be related to poor outcome after use of intravenous tissue plasminogen activator in AIS.
Keywords
Leukoaraiosis; Intracerebral hemorrhage; Thrombolysis; Acute ischemic stroke;
Citations & Related Records

Times Cited By Web Of Science : 0  (Related Records In Web of Science)
Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, et al. : Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice : the Multicenter rt-PA Stroke Survey. Circulation 105 : 1679-1685, 2002   DOI   ScienceOn
2 The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group : Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 : 1581-1587, 1995   DOI   ScienceOn
3 Thein SS, Hamidon BB, Teh HS, Raymond AA : Leukoaraiosis as a predictor for mortality and morbidity after an acute ischaemic stroke. Singapore Med J 48 : 396-399, 2007
4 van Swieten JC, Kappelle LJ, Algra A, van Latum JC, Koudstaal PJ, van Gijn J : Hypodensity of the cerebral white matter in patients with transient ischemic attack or minor stroke : influence on the rate of subsequent stroke. Dutch TIA Trial Study Group. Ann Neurol 32 : 177-183, 1992   DOI   ScienceOn
5 Weimar C, KÖnig IR, Kraywinkel K, Ziegler A, Diener HC : Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia : development and external validation of prognostic models. Stroke 35 : 158-162, 2004
6 Whitman GT, Tang Y, Lin A, Baloh RW : A prospective study of cerebral white matter abnormalities in older people with gait dysfunction. Neurology 57 : 990-994, 2001   DOI   ScienceOn
7 Yamanouchi H, Sugiura S, Tomonaga M : Decrease in nerve fibres in cerebral white matter in progressive subcortical vascular encephalopathy of Binswanger type. An electron microscopic study. J Neurol 236 : 382-387, 1989   DOI   ScienceOn
8 Iwamoto T, Kubo H, Takasaki M : Platelet activation in the cerebral circulation in different subtypes of ischemic stroke and Binswanger's disease. Stroke 26 : 52-56, 1995   DOI   ScienceOn
9 Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS : Leukoaraiosis in stroke patients. The Copenhagen Stroke Study. Stroke 26 : 588-592, 1995   DOI   ScienceOn
10 Koennecke HC : Cerebral microbleeds on MRI : prevalence, associations, and potential clinical implications. Neurology 66 : 165-171, 2006   DOI   ScienceOn
11 Lee SJ, Kim JS, Lee KS, An JY, Kim W, Kim YI, et al. : The leukoaraiosis is more prevalent in the large artery atherosclerosis stroke subtype among Korean patients with ischemic stroke. BMC Neurol 8 : 31, 2008   DOI
12 Longstreth WT Jr, Bernick C, Manolio TA, Bryan N, Jungreis CA, Price TR : Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people : the Cardiovascular Health Study. Arch Neurol 55 : 1217-1225, 1998   DOI   ScienceOn
13 Neumann-Haefelin T, Hoelig S, Berkefeld J, Fiehler J, Gass A, Humpich M, et al. : Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke 37 : 2463-2466, 2006   DOI   ScienceOn
14 Nordahl CW, Ranganath C, Yonelinas AP, Decarli C, Fletcher E, Jagust WJ : White matter changes compromise prefrontal cortex function in healthy elderly individuals. J Cogn Neurosci 18 : 418-429, 2006   DOI   ScienceOn
15 O'Sullivan M, Lythgoe DJ, Pereira AC, Summers PE, Jarosz JM, Williams SC, et al. : Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 59 : 321-326, 2002   DOI   ScienceOn
16 Smith EE, Rosand J, Knudsen KA, Hylek EM, Greenberg SM : Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology 59 : 193-197, 2002   DOI   ScienceOn
17 Pantoni L, Garcia JH : Pathogenesis of leukoaraiosis : a review. Stroke 28 : 652-659, 1997   DOI   ScienceOn
18 A, et al. : Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Ann Neurol 63 : 52-60, 2008   DOI   ScienceOn
19 Smith EE : Leukoaraiosis and stroke. Stroke 41 : S139-S143, 2010   DOI   ScienceOn
20 Aries MJ, Uyttenboogaart M, Vroomen PC, De Keyser J, Luijckx GJ : tPA treatment for acute ischaemic stroke in patients with leukoaraiosis. Eur J Neurol 17 : 866-870, 2010   DOI   ScienceOn
21 Arsava EM, Rahman R, Rosand J, Lu J, Smith EE, Rost NS, et al. : Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke. Neurology 72 : 1403-1410, 2009   DOI   ScienceOn
22 de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, et al. : Prevalence of cerebral white matter lesions in elderly people : a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 70 : 9-14, 2001   DOI   ScienceOn
23 del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M : PROACT : a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 29 : 4-11, 1998   DOI   ScienceOn
24 del Zoppo GJ, von Kummer R, Hamann GF : Ischaemic damage of brain microvessels : inherent risks for thrombolytic treatment in stroke. J Neurol Neurosurg Psychiatry 65 : 1-9, 1998   DOI   ScienceOn
25 Demchuk AM, Khan F, Hill MD, Barber PA, Silver B, Patel S, et al. : Importance of leukoaraiosis on CT for tissue plasminogen activator decision making : evaluation of the NINDS rt-PA Stroke Study. Cerebrovasc Dis 26 : 120-125, 2008   DOI   ScienceOn
26 Hachinski VC, Potter P, Merskey H : Leuko-araiosis. Arch Neurol 44 : 21-23, 1987   DOI   ScienceOn
27 Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA : MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 149 : 351-356, 1987   DOI   ScienceOn
28 GÖrner A, Lemmens R, Schrooten M, Thijs V : is leukoaraiosis on CT an accurate surrogate marker for the presence of microbleeds in acute stroke patients? J Neurol 254 : 284-289, 2007   DOI   ScienceOn
29 Gorter JW : Major bleeding during anticoagulation after cerebral ischemia : patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology 53 : 1319-1327, 1999   DOI
30 Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. : Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.Lancet 352 : 1245-1251, 1998   DOI   ScienceOn